Lilly’s weight-loss treatment Zepbound becomes first FDA-approved drug for sleep apnea
By Bhanvi Satija (Reuters) -The U.S. Food and Drug Administration on Friday approved Eli Lilly (NYSE:LLY)’s weight-loss treatment, Zepbound, for...
Read moreBy Bhanvi Satija (Reuters) -The U.S. Food and Drug Administration on Friday approved Eli Lilly (NYSE:LLY)’s weight-loss treatment, Zepbound, for...
Read moreBy David Shepardson WASHINGTON (Reuters) -The U.S. Commerce Department said on Friday it was finalizing an award of up to...
Read moreInvesting.com — Qualcomm Inc . (NASDAQ:QCOM) shares climbed 2.6% in after hours trading following a favorable legal outcome in its...
Read moreInvesting.com – Russia stocks were higher after the close on Friday, as gains in the Telecoms, Mining and Oil &...
Read moreInvesting.com – Colombia stocks were lower after the close on Friday, as losses in the Financials, Investment and Public Services...
Read moreInvesting.com – Brazil stocks were higher after the close on Friday, as gains in the Real Estate, Consumption and Financials...
Read moreInvesting.com — Boston Beer Company Inc (NYSE:SAM) cut its full-year GAAP earnings per share guidance to $3.80-$5.80, down from $5.50-$7.50. ...
Read moreBy Alexandra Alper and Karen Freifeld (Reuters) – The Biden administration plans to blacklist a Chinese company whose TSMC-made chip...
Read moreBy Abhijith Ganapavaram (Reuters) -FedEx’s decision to spin off its freight trucking unit will strengthen that business while allowing the...
Read moreInvesting.com — Shares of Cytokinetics (NASDAQ:CYTK), Incorporated (NASDAQ:CYTK) climbed 4.8% after the company announced that Sanofi (NASDAQ:SNY) will acquire exclusive...
Read moreCopyright © 2024 Usnationtreasure.com All Rights Reserved.